Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 232-234

  El Omar, Magdi M ^a   Dangas, George ^a   Mehran, Roxana ^a   Lansky, Alexandra J ^a   Kipshidze, Nicholas N ^a   Polena, Sotir ^a   Fahy, Martin ^a   Moussa, Issam ^a   Glasser, Lynne ^a   Moses, Jeffrey W ^a   Stone, Gregg W ^a   Leon, Martin B ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; Q WAVE; REVASCULARIZATION; RISK ASSESSMENT; SINUS RHYTHM; STENOSIS; THROMBUS; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL FIBRILLATION; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037298845     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03114-4     Document Type: Article

References (15)

1. Hogue C.W. Jr, Hyder M.L. Atrial fibrillation after cardiac operation risks, mechanisms, and treatment. Ann Thorac Surg. 69:2000;300-306.
2. Stamou S.C., Dangas G., Hill P.C., Pfister A.J., Dullum M.K., Boyce S.W., Bafi A.S., Garcia J.M., Corso P.J. Atrial fibrillation after beating heart surgery. Am J Cardiol. 86:2000;64-67.
3. Polanczyk C.A., Goldman L., Marcantonio E.R., Orav E.J., Lee T.H. Supraventricular arrhythmia in patients having noncardiac surgery clinical correlates and effect on length of stay. Ann Intern Med. 129:1998;279-285.
4. Rathore S.S., Berger A.K., Weinfurt K.P., Schulman K.A., Oetgen W.J., Gersh B.J., Solomon A.J. Acute myocardial infarction complicated by atrial fibrillation in the elderly prevalence and outcomes. Circulation. 101:2000;969-974.
5. Smith S.C. Jr, Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., Williams D.O., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 103:2001;3019-3041.
6. Campeau L. Grading of angina pectoris. (letter) Circulation. 54:1976;522-523.
7. Lansky A.J., Popma J.J. Qualitative and quantitative angiography. Topol E. Textbook of Interventional Cardiology. 1999;725-747 WB Saunders, Philadelphia, PA.
8. Chesebro J.H., Fuster V., Halperin J.L. Atrial fibrillation-risk marker for stroke. N Engl J Med. 323:1990;1556-1558.
9. Lip G.Y. Does atrial fibrillation confer a hypercoagulable state? Lancet. 346:1995;1313-1314.
10. Feng D., D'Agostino R.B., Silbershatz H., Lipinska I., Massaro J., Levy D., Benjamin E.J., Wolf P.A., Totler G.H. Haemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol. 87:2001;168-171.
11. Lip G.Y., Edmunds E., Beevers D.G. Should patients with hypertension receive antithrombotic therapy? J Intern Med. 249:2001;205-214.
12. Carr M.E. Diabetes mellitus a hypercoagulable state. J Diabetes Complications. 15:2001;44-54.
13. Garg R.K., Gheorghiade M., Jafri S.M. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure. Prog Cardiovasc Dis. 41:1998;225-236.
14. Vaziri N.D., Gonzales E.C., Wang J., Said S. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease effect of hemodialysis. Am J Kidney Dis. 23:1994;828-835.
15. Schafer A.I. The hypercoagulable states. Ann Intern Med. 102:1985;814-828.